Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Ware

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
The Journal of Extra-Corporeal Technology|August 6, 1995
Management considerations for a heterozygous protein C deficient patient undergoing open heart surgery with cardiopulmonary bypassD S Lawson, E M Darling, R E Ware, et al.
Journal of Pediatric Psychology|March 22, 2001
Daily coping practice predicts treatment effects in children with sickle cell diseaseK M Gil, K K Anthony, J W Carson, et al.
The Journal of Pediatrics|December 18, 2001
A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemiaW C Wang, L W Wynn, Z R Rogers, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Structure-function relationships of the complement regulatory protein, CD59J Petranka, J Zhao, J Norris, et al.
International Immunology|October 1, 1991
Analysis of clones derived from human CD7+CD4-CD8-CD3- thymocytesS M Denning, D M Jones, R E Ware, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Thrombophilic DNA Mutations As Independent Risk Factors for Stroke and Avascular Necrosis in Sickle Cell AnemiaS A Zimmerman, T A Howard, M R Whorton, et al.
Blood|June 22, 2001
Defective binding of factor XI-N248 to activated human plateletsM F Sun, F A Baglia, D Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Characterization of the surface topography and putative tertiary structure of the human CD7 moleculeR E Ware, R M Scearce, M A Dietz, et al.
Blood|May 29, 2000
Acquired DNA mutations associated with in vivo hydroxyurea exposureV N Hanft, S R Fruchtman, C V Pickens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratificationR J Hicks, V Kalff, M P MacManus, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
The Journal of Extra-Corporeal Technology|August 6, 1995
Management considerations for a heterozygous protein C deficient patient undergoing open heart surgery with cardiopulmonary bypassD S Lawson, E M Darling, R E Ware, et al.
Journal of Pediatric Psychology|March 22, 2001
Daily coping practice predicts treatment effects in children with sickle cell diseaseK M Gil, K K Anthony, J W Carson, et al.
The Journal of Pediatrics|December 18, 2001
A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemiaW C Wang, L W Wynn, Z R Rogers, et al.
Blood Cells, Molecules & Diseases|January 1, 1996
Structure-function relationships of the complement regulatory protein, CD59J Petranka, J Zhao, J Norris, et al.
International Immunology|October 1, 1991
Analysis of clones derived from human CD7+CD4-CD8-CD3- thymocytesS M Denning, D M Jones, R E Ware, et al.
Hematology (Amsterdam, Netherlands)|July 14, 2016
Thrombophilic DNA Mutations As Independent Risk Factors for Stroke and Avascular Necrosis in Sickle Cell AnemiaS A Zimmerman, T A Howard, M R Whorton, et al.
Blood|June 22, 2001
Defective binding of factor XI-N248 to activated human plateletsM F Sun, F A Baglia, D Ho, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1989
Characterization of the surface topography and putative tertiary structure of the human CD7 moleculeR E Ware, R M Scearce, M A Dietz, et al.
Blood|May 29, 2000
Acquired DNA mutations associated with in vivo hydroxyurea exposureV N Hanft, S R Fruchtman, C V Pickens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratificationR J Hicks, V Kalff, M P MacManus, et al.
Pageof 11